ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 1 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $24,000 | +33.3% | 22,977 | -2.4% | 0.00% | – |
Q4 2018 | $18,000 | -64.0% | 23,538 | 0.0% | 0.00% | – |
Q3 2018 | $50,000 | -7.4% | 23,538 | -0.0% | 0.00% | – |
Q2 2018 | $54,000 | -37.2% | 23,539 | -12.7% | 0.00% | – |
Q1 2018 | $86,000 | -26.5% | 26,953 | -6.1% | 0.00% | – |
Q4 2017 | $117,000 | +10.4% | 28,707 | +22.0% | 0.00% | – |
Q3 2017 | $106,000 | +35.9% | 23,538 | -0.0% | 0.00% | – |
Q2 2017 | $78,000 | -92.3% | 23,539 | -78.5% | 0.00% | – |
Q1 2017 | $1,007,000 | +25.6% | 109,273 | +5.1% | 0.00% | – |
Q4 2016 | $802,000 | -31.5% | 103,968 | +1.6% | 0.00% | – |
Q3 2016 | $1,170,000 | +5.8% | 102,347 | +13.9% | 0.00% | – |
Q2 2016 | $1,106,000 | +27.9% | 89,819 | +4.9% | 0.00% | – |
Q1 2016 | $865,000 | -40.6% | 85,593 | +32.6% | 0.00% | – |
Q4 2015 | $1,456,000 | +36.7% | 64,556 | +0.6% | 0.00% | – |
Q3 2015 | $1,065,000 | -34.4% | 64,183 | -11.1% | 0.00% | – |
Q2 2015 | $1,624,000 | +13.8% | 72,162 | +30.4% | 0.00% | – |
Q1 2015 | $1,427,000 | +0.6% | 55,360 | -15.0% | 0.00% | – |
Q4 2014 | $1,418,000 | +20.5% | 65,111 | +4.8% | 0.00% | – |
Q3 2014 | $1,177,000 | -52.1% | 62,141 | -41.1% | 0.00% | – |
Q2 2014 | $2,456,000 | +137.1% | 105,438 | +242.5% | 0.00% | – |
Q1 2014 | $1,036,000 | +82.7% | 30,782 | +60.1% | 0.00% | – |
Q4 2013 | $567,000 | – | 19,229 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 4,042,989 | $8,571,000 | 0.75% |
NEXTHERA CAPITAL LP | 634,715 | $1,346,000 | 0.26% |
Endurant Capital Management LP | 219,114 | $465,000 | 0.21% |
Birchview Capital, LP | 118,689 | $252,000 | 0.16% |
Perceptive Advisors | 2,620,897 | $5,556,000 | 0.15% |
Alambic Investment Management, L.P. | 53,972 | $114,000 | 0.09% |
Sofinnova Investments, Inc. | 395,744 | $839,000 | 0.08% |
Kazazian Asset Management, LLC | 31,475 | $67,000 | 0.06% |
Broadfin Capital, LLC | 200,000 | $424,000 | 0.06% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 96,639 | $205,000 | 0.02% |